Structural changes of corneal epithelium in belantamab-associated superficial keratopathy using anterior segment optical coherence tomography

Corneal Epithelial Thickness Measured Using AS-OCT as a Diagnostic Parameter for Limbal Stem Cell Deficiency

(2020) Qingfeng Liang et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Patient Selection Strategies to Maximize Therapeutic Index of Antibody Drug Conjugates: Prior Approaches and Future Directions

(2020) Marna Williams et al.   MOLECULAR CANCER THERAPEUTICS

Corneal Changes After Belantamab Mafodotin in Multiple Myeloma Patients

(2020) Rebecca B. Bausell et al.   Eye & Contact Lens-Science and Clinical Practice

Belantamab Mafotodin-Induced Epithelial Keratopathy Masquerading Myopic Surgery

(2020) Antoine Rousseau et al.   OPHTHALMOLOGY

In Vivo Confocal Microscopy and Anterior Segment Optical Coherence Tomography Analysis of the Microcystic Keratitis

(2020) Michał Dembski et al.   Journal of Ophthalmology

Anterior Segment Optical Coherence Tomography Images in Microsporidial Keratoconjunctivitis

(2019) Onsiri Thanathanee et al.   CORNEA

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

(2019) Joseph Mikhael et al.   JOURNAL OF CLINICAL ONCOLOGY

Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates

(2019) Prathap Kumar Mahalingaiah et al.   PHARMACOLOGY & THERAPEUTICS

Relapsed refractory multiple myeloma: a comprehensive overview

(2019) Abdul Hamid Bazarbachi et al.   LEUKEMIA

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

(2019) Sagar Lonial et al.   LANCET ONCOLOGY

Anterior segment optical coherence tomography scanning protocols and corneal thickness repeatability

(2019) Damien Fisher et al.   Contact Lens & Anterior Eye

Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates

(2018) Hui Zhao et al.   CANCER RESEARCH

Resistance to Antibody–Drug Conjugates

(2018) Sara García-Alonso et al.   CANCER RESEARCH

FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia

(2018) Emily Y. Jen et al.   CLINICAL CANCER RESEARCH

In vivo histology and p.L132V mutation in KRT12 gene in Japanese patients with Meesmann corneal dystrophy

(2018) Tsubasa Nishino et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

(2018) Suzanne Trudel et al.   LANCET ONCOLOGY

Drug-induced corneal epithelial changes

(2017) Michael B. Raizman et al.   SURVEY OF OPHTHALMOLOGY

Ocular Adverse Events Associated with Antibody–Drug Conjugates in Human Clinical Trials

(2015) Joshua Seth Eaton et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Clinical Applications of Anterior Segment Optical Coherence Tomography

(2015) Su-Ho Lim   Journal of Ophthalmology

Concise Review: Identifying Limbal Stem Cells: Classical Concepts and New Challenges

(2013) Aaron W. Joe et al.   Stem Cells Translational Medicine

Drug-conjugated antibodies for the treatment of cancer

(2012) John M. Lambert   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Brentuximab Vedotin (SGN-35)

(2011) J. Katz et al.   CLINICAL CANCER RESEARCH

Multiple Myeloma

(2011) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Corneal epithelial proliferation and thickness in a mouse model of dry eye

(2009) Claudia Fabiani et al.   EXPERIMENTAL EYE RESEARCH